All In Biotech

Drug Trial Radar · NCT02008123

Effect of Primidone on Platelet Responsiveness in Patients Determined to be Clopidogrel Resistant

Last checked: Nov 19, 2026Latest source record: Aug 3, 2016 (this record)Source: ClinicalTrials.govMethods & limitations

Withdrawn

Status

Withdrawn

Enrollment

0

Actual

Start

Aug 2013

Primary completion

Dec 2017

Sponsor

Lead sponsor
Dent Neuroscience Research CenterAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Dec 11, 2013

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 90 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to determine whether adding primidone will improve the metabolism of clopidogrel thereby increasing metabolite levels within the blood stream and platelet response to clopidogrel in patients who were previously found to lack adequate response to clopidogrel. This information could help overcome clopidogrel resistance in patients who are at risk for stroke or transient ischemic attack (TIA).

Conditions

  • Clopidogrel Resistance
  • Secondary Stroke Prevention

Interventions

  • PrimidoneDrug

    Primidone is an antiepileptic used for the management of generalized tonic-clonic seizures and for the management of complex partial seizures. One of primidone's active metabolite is phenobarbital, which is a potent cytochrome P450 inducer. In this study, primidone will be used to induce CYP 1A2 in order to provide more efficient metabolism of clopidogrel to its active form

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Platelet AggregometryTime frame: Platelet aggregometry will be performed at Visit 1 and Visit 2 which will be 20-28 days following Visit 1.

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Dent Neurologic Institute

    Amherst, New York

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.